Altered ROS production, NF-κB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 7, 2015, Pages 1410-1419

  Henríquez Olguín, Carlos ^a,c   Altamirano, Francisco ^a,b   Valladares, Denisse ^a   López, José R ^b   Allen, Paul D ^b   Jaimovich, Enrique ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Laboratory of Exercise Science   (Chile)

Author keywords

Calcium; Duchenne muscular dystrophy; Interleukin 6; Membrane depolarization; NF B; Reactive oxygen species

Indexed keywords

DYSTROPHIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME INHIBITION; GENE EXPRESSION; INFLAMMATION; MEMBRANE DEPOLARIZATION; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; ANIMAL; CELL CULTURE; DUCHENNE MUSCULAR DYSTROPHY; GENETICS; MEMBRANE POTENTIAL; METABOLISM; PHYSIOLOGY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CALCIUM; CELLS, CULTURED; ELECTRIC STIMULATION; INTERLEUKIN-6; MEMBRANE POTENTIALS; MICE; MICE, INBRED MDX; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NF-KAPPA B; REACTIVE OXYGEN SPECIES;

EID: 84927939371     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.03.012     Document Type: Article

References (59)

1. Blake D.J., Weir A., Newey S.E., Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 2002, 82:291-329.
2. Emery A.E. The muscular dystrophies. Lancet 2002, 359:687-695.
3. Sockolov R., Irwin B., Dressendorfer R.H., Bernauer E.M. Exercise performance in 6-to-11-year-old boys with Duchenne muscular dystrophy. Arch. Phys. Med. Rehabil. 1977, 58:195-201.
4. Sandri M., Podhorska-Okolow M., Geromel V., Rizzi C., Arslan P., Franceschi C., Carraro U. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J. Neuropathol. Exp. Neurol. 1997, 56:45-57.
5. Vilquin J.T., Brussee V., Asselin I., Kinoshita I., Gingras M., Tremblay J.P. Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve 1998, 21:567-576.
6. Gordon B.S., Lowe D.A., Kostek M.C. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 2014, 49:915-918.
7. Evans N.P., Misyak S.A., Robertson J.L., Bassaganya-Riera J., Grange R.W. Immune-mediated mechanisms potentially regulate the disease time-course of Duchenne muscular dystrophy and provide targets for therapeutic intervention. PM R 2009, 1:755-768.
8. Tidball J.G. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R345-R353.
9. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011, 1813:878-888.
10. Kurek J.B., Nouri S., Kannourakis G., Murphy M., Austin L. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve 1996, 19:1291-1301.
11. Messina S., Vita G.L., Aguennouz M., Sframeli M., Romeo S., Rodolico C., Vita G. Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age. Acta Myol. 2011, 30:16-23.
12. Altamirano F., Lopez J.R., Henriquez C., Molinski T., Allen P.D., Jaimovich E. Increased resting intracellular calcium modulates NF-kappaB-dependent inducible nitric-oxide synthase gene expression in dystrophic mdx skeletal myotubes. J. Biol. Chem. 2012, 287:20876-20887.
13. Pedersen B.K. Muscular interleukin-6 and its role as an energy sensor. Med. Sci. Sports Exerc. 2012, 44:392-396.
14. 2+ transients stimulate transcription of IL-6 gene in skeletal muscle cells. Am. J. Physiol. Cell Physiol. 2006, 290:C1428-C1436.
15. Kosmidou I., Vassilakopoulos T., Xagorari A., Zakynthinos S., Papapetropoulos A., Roussos C. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am. J. Respir. Cell Mol. Biol. 2002, 26:587-593.
16. Valdes J.A., Hidalgo J., Galaz J.L., Puentes N., Silva M., Jaimovich E., Carrasco M.A. NF-kappaB activation by depolarization of skeletal muscle cells depends on ryanodine and IP3 receptor-mediated calcium signals. Am. J. Physiol. Cell Physiol. 2007, 292:C1960-C1970.
17. Gomez-Cabrera M.C., Domenech E., Vina J. Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. Free Radic. Biol. Med. 2008, 44:126-131.
18. Sakellariou G.K., Vasilaki A., Palomero J., Kayani A., Zibrik L., McArdle A., Jackson M.J. Studies of mitochondrial and nonmitochondrial sources implicate nicotinamide adenine dinucleotide phosphate oxidase(s) in the increased skeletal muscle superoxide generation that occurs during contractile activity. Antioxid. Redox Signal. 2013, 18:603-621.
19. Michaelson L.P., Shi G., Ward C.W., Rodney G.G. Mitochondrial redox potential during contraction in single intact muscle fibers. Muscle Nerve 2010, 42:522-529.
20. Pal R., Basu Thakur P., Li S., Minard C., Rodney G.G. Real-time imaging of NADPH oxidase activity in living cells using a novel fluorescent protein reporter. PLoS One 2013, 8:e63989.
21. Hidalgo C., Sanchez G., Barrientos G., Aracena-Parks P. A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S-glutathionylation. J. Biol. Chem. 2006, 281:26473-26482.
22. Pal R., Palmieri M., Loehr J.A., Li S., Abo-Zahrah R., Monroe T.O., Thakur P.B., Sardiello M., Rodney G.G. Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy. Nat. Commun. 2014, 5:4425.
23. White N.P., Yeung E.W., Froehner S.C., Allen D.G. Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse. PLoS One 2010, 5:e15354.
24. Rando T.A., Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 1994, 125:1275-1287.
25. Casas M., Altamirano F., Jaimovich E. Myogenesis: Methods and Protocols 2011, Humana Press. 1st ed.
26. Jorquera G., Altamirano F., Contreras-Ferrat A., Almarza G., Buvinic S., Jacquemond V., Jaimovich E., Casas M. Cav1.1 controls frequency-dependent events regulating adult skeletal muscle plasticity. J. Cell Sci. 2013, 126:1189-1198.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
28. Marshall O.J. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 2004, 20:2471-2472.
29. Welc S.S., Clanton T.L. The regulation of interleukin-6 implicates skeletal muscle as an integrative stress sensor and endocrine organ. Exp. Physiol. 2013, 98:359-371.
30. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 1995, 270:14255-14258.
31. Pedersen B.K. Muscle as a secretory organ. Compr. Physiol. 2013, 3:1337-1362.
32. 2+ release and generates hydrogen peroxide, which jointly stimulate NF-kappaB activity. Antioxid. Redox Signal. 2011, 14:1245-1259.
33. Sakellariou G.K., Jackson M.J., Vasilaki A. Redefining the major contributors to superoxide production in contracting skeletal muscle. The role of NAD(P)H oxidases. Free Radic. Res. 2014, 48:12-29.
34. Morgan M.J., Liu Z.G. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011, 21:103-115.
35. Khairallah R.J., Shi G., Sbrana F., Prosser B.L., Borroto C., Mazaitis M.J., Hoffman E.P., Mahurkar A., Sachs F., Sun Y., Chen Y.W., Raiteri R., Lederer W.J., Dorsey S.G., Ward C.W. Microtubules underlie dysfunction in Duchenne muscular dystrophy. Sci. Signal. 2012, 5:ra56.
36. Ragusa R.J., Chow C.K., Porter J.D. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul. Disord. 1997, 7:379-386.
37. Shkryl V.M., Martins A.S., Ullrich N.D., Nowycky M.C., Niggli E., Shirokova N. Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers. Pflugers Arch. 2009, 458:915-928.
38. Altamirano F., Valladares D., Henriquez-Olguin C., Casas M., Lopez J.R., Allen P.D., Jaimovich E. Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice. PLoS One 2013, 8:e81222.
39. Mourkioti F., Rosenthal N. NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases. J. Mol. Med. 2008, 86:747-759.
40. Schaecher K., Goust J.M., Banik N.L. The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem. Res. 2004, 29:1443-1451.
41. Acharyya S., Villalta S.A., Bakkar N., Bupha-Intr T., Janssen P.M., Carathers M., Li Z.W., Beg A.A., Ghosh S., Sahenk Z., Weinstein M., Gardner K.L., Rafael-Fortney J.A., Karin M., Tidball J.G., Baldwin A.S., Guttridge D.C. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest. 2007, 117:889-901.
42. Vella L., Caldow M.K., Larsen A.E., Tassoni D., Della Gatta P.A., Gran P., Russell A.P., Cameron-Smith D. Resistance exercise increases NF-kappaB activity in human skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:R667-R673.
43. Tantiwong P., Shanmugasundaram K., Monroy A., Ghosh S., Li M., DeFronzo R.A., Cersosimo E., Sriwijitkamol A., Mohan S., Musi N. NF-kappaB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E794-E801.
44. Hyldahl R.D., Xin L., Hubal M.J., Moeckel-Cole S., Chipkin S., Clarkson P.M. Activation of nuclear factor-kappaB following muscle eccentric contractions in humans is localized primarily to skeletal muscle-residing pericytes. FASEB J. 2011, 25:2956-2966.
45. Scheler M., Irmler M., Lehr S., Hartwig S., Staiger H., Al-Hasani H., Beckers J., Hrabe de Angelis M., Haring H.U., Weigert C. The cytokine response of primary human myotubes in an in vitro exercise model. Am. J. Physiol. Cell Physiol. 2013, 305(8):C877-C886.
46. Sasaki C.Y., Barberi T.J., Ghosh P., Longo D.L. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J. Biol. Chem. 2005, 280:34538-34547.
47. Beraud C., Henzel W.J., Baeuerle P.A. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:429-434.
48. Kelleher Z.T., Matsumoto A., Stamler J.S., Marshall H.E. NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J. Biol. Chem. 2007, 282:30667-30672.
49. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 1996, 24:2236-2242.
50. Nakajima S., Kitamura M. Bidirectional regulation of NF-kappaB by reactive oxygen species: a role of unfolded protein response. Free Radic. Biol. Med. 2013, 65:162-174.
51. Kefaloyianni E., Gaitanaki C., Beis I. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell. Signal. 2006, 18:2238-2251.
52. Fischer C.P., Hiscock N.J., Penkowa M., Basu S., Vessby B., Kallner A., Sjoberg L.B., Pedersen B.K. Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle. J. Physiol. 2004, 558:633-645.
53. Call J.A., McKeehen J.N., Novotny S.A., Lowe D.A. Progressive resistance voluntary wheel running in the mdx mouse. Muscle Nerve 2010, 42:871-880.
54. Landisch R.M., Kosir A.M., Nelson S.A., Baltgalvis K.A., Lowe D.A. Adaptive and nonadaptive responses to voluntary wheel running by mdx mice. Muscle Nerve 2008, 38:1290-1303.
55. Serrano A.L., Baeza-Raja B., Perdiguero E., Jardi M., Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008, 7:33-44.
56. Fujimori K., Itoh Y., Yamamoto K., Miyagoe-Suzuki Y., Yuasa K., Yoshizaki K., Yamamoto H., Takeda S. Interleukin 6 induces overexpression of the sarcolemmal utrophin in neonatal mdx skeletal muscle. Hum. Gene Ther. 2002, 13:509-518.
57. Pillon N.J., Bilan P.J., Fink L.N., Klip A. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E453-E465.
58. Zhang C., Li Y., Wu Y., Wang L., Wang X., Du J. Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J. Biol. Chem. 2013, 288:1489-1499.
59. Kostek M.C., Nagaraju K., Pistilli E., Sali A., Lai S.H., Gordon B., Chen Y.W. IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse. BMC Musculoskelet. Disord. 2012, 13:106.